Cargando…

Imaging for Dupuytren disease: a systematic review of the literature

BACKGROUND: As treatment of Dupuytren disease (DD) is expected to shift towards prevention of progression, the use of imaging in patients with DD becomes more important. In this systematic review an overview is given of the different methods for and applications of imaging for DD that have been desc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molenkamp, Sanne, van Straalen, Roel J. M., Werker, Paul M. N., Broekstra, Dieuwke C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525391/ https://www.ncbi.nlm.nih.gov/pubmed/31101038 http://dx.doi.org/10.1186/s12891-019-2606-0

Ejemplares similares

Echogenicity of Dupuytren’s nodules is correlated to myofibroblast load and nodule hardness
por: Molenkamp, Sanne, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis on the Strength and Consistency of the Associations between Dupuytren Disease and Diabetes Mellitus, Liver Disease, and Epilepsy
por: Broekstra, Dieuwke C., et al.
Publicado: (2018)

Patient-Perceived Hand Function Can Predict Treatment for Dupuytren Disease
por: van den Berge, Bente A., et al.
Publicado: (2023)

Dupuytren’s disease is a work-related disorder: results of a population-based cohort study
por: van den Berge, Bente A., et al.
Publicado: (2023)

Measurement properties of the Dutch Unité Rhumatologique des Affections de la Main and its ability to measure change due to Dupuytren’s disease progression compared with the Michigan Hand outcomes Questionnaire
por: Broekstra, Dieuwke C., et al.
Publicado: (2018)

A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren’s Disease
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis
por: Broekstra, Dieuwke C., et al.
Publicado: (2022)

Matrix and cell phenotype differences in Dupuytren’s disease
por: van Beuge, Marike M., et al.
Publicado: (2016)

Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease
por: ten Dam, Evert-Jan P. M., et al.
Publicado: (2015)

Dupuytren’s disease: using needles more across the world
por: Warwick, David, et al.
Publicado: (2021)

Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

Dupuytren's Disease: Review of the Current Literature
por: Khashan, Morsi, et al.
Publicado: (2011)

Dutch Multidisciplinary Guideline on Dupuytren Disease
por: Kemler, Marius A., et al.
Publicado: (2022)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
por: Puerta Cavanzo, Nataly, et al.
Publicado: (2022)

Recent Surgical and Medical Advances in the Treatment of Dupuytren’s Disease - A Systematic Review of the Literature
por: R, Mafi, et al.
Publicado: (2012)

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis
por: Ng, Michael, et al.
Publicado: (2017)

Corticosteroid Injection in the Management of Dupuytren Nodules: A Review of the Literature
por: Sood, Aditya, et al.
Publicado: (2015)

Systematic review of non-surgical treatments for early dupuytren’s disease
por: Ball, Catherine, et al.
Publicado: (2016)

Paediatric Dupuytren's disease
por: Korambayil, Pradeoth Mukundan, et al.
Publicado: (2011)

Sorafenib in Dupuytren and Ledderhose Disease
por: Schoenfeld, Joshua D, et al.
Publicado: (2022)

Paediatric Dupuytren’s Disease in a Child of Indian Ethnicity: A Case Report and Literature Review
por: Beecher, Suzanne M, et al.
Publicado: (2021)

The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis
por: Salari, Nader, et al.
Publicado: (2020)

Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013)

Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012)

Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis
por: Wong, Chloe R., et al.
Publicado: (2021)

Dupuytren's Disease: the Vikings Disease in Koreans
por: Gong, Hyun Sik
Publicado: (2018)

The Role of Stem Cells in Dupuytren’s Disease: A Review
por: Tan, Kirin, et al.
Publicado: (2018)

Surgical Complications Associated With Fasciectomy for Dupuytren's Disease: A 20-Year Review of the English Literature
por: Denkler, Keith
Publicado: (2010)

Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019)

Dupuytren's: a systems biology disease
por: Rehman, Samrina, et al.
Publicado: (2011)

The Rationale for Treating the Nodule in Dupuytren’s Disease
por: Ketchum, Lynn D.
Publicado: (2015)

Dupuytren’s disease and the risk of malignant neoplasms
por: Żyluk, Andrzej, et al.
Publicado: (2014)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

Epidemiological analysis of patients with Dupuytren's disease()
por: Mansur, Henrique Gonçalves, et al.
Publicado: (2017)

Surgical treatment results for dupuytren's disease
por: Aykut, Serkan, et al.
Publicado: (2017)

EPIDEMIOLOGICAL ASPECTS OF DUPUYTREN'S DISEASE IN BRAZIL
por: Nakamoto, Hugo Alberto, et al.
Publicado: (2022)

Embryonic Stem Cell–like Population in Dupuytren’s Disease
por: Koh, Sabrina P., et al.
Publicado: (2016)

A new bromelain-based enzyme for the release of Dupuytren’s contracture: Dupuytren’s enzymatic bromelain-based release
por: Rubin, G., et al.
Publicado: (2016)

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
por: Ganesan, Sandhya, et al.
Publicado: (2023)

Dupuytren's Treatment of Scrofula
Publicado: (1830)

Cannot write session to /tmp/vufind_sessions/sess_d17a9843bcq0vmn611n6cavk25